|
Title
|
Credit (Amnt/Type)
|
Est.Time
|
Expires
|
2011-2012 UMDNJ PA Certification and Recertification Examination Review Course Module 5: Reproductive System, Endocrine System, Genitourinary System, Hematologic System
|
6.25
/
AAPA Category I CME Credit
|
6.25 Hours
|
October 17, 2012
|
|
Abiraterone Acetate plus Prednisone Demonstrates Better Pain Control vs Prednisone Alone in Patients with Metastatic Castration-Resistant Prostate Cancer
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
30 minutes
|
September 06, 2012
|
|
Adjuvant Chemotherapy and Radiation following PDD for Pancreatic Adenocarcinoma: Summary of Trials and Future Directions
|
1.00
/
AMA PRA Category 1 Credit(s)TM
|
1 Hour
|
March 15, 2010
|
|
Adjuvant Therapy for Malignant Melanoma: Targeted Pathways to Antitumor Potential and Better Outcomes
|
2.00
/
AMA PRA Category 1 Credit(s)TM
1.50
/
CE for Nurses
|
1.5– 2 Hours
|
December 31, 2010
|
|
Adjuvant Treatment with Zoledronic Acid Does Not Improve Disease-Free Survival in Stage II/III Breast Cancer
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
30 minutes
|
February 29, 2012
|
|
Androgen Deprivation Therapy in Prostate Cancer: Addressing Clinical Challenges
|
1.00
/
AMA PRA Category 1 Credit(s)TM
|
1 hour
|
January 04, 2012
|
|
Bortezomib + Rituximab in Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma vs Rituximab Alone
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
0.5 hours
|
January 31, 2012
|
|
Bosutinib or Imatinib Safe, Effective in Patients with Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
0.5 hours
|
January 31, 2012
|
Carcinoma of Unknown Primary:
Changing Paradigm in the Era of Molecular Profiling
|
1.00
/
AMA PRA Category 1 Credit(s)TM
|
1 Hour
|
June 15, 2010
|
|
Carcinoma of unknown primary; Acute achilles tendon rupture
|
1.00
/
AAPA Category I CME Credit
|
1 Hour
|
August 31, 2010
|